Biodexa Pharmaceuticals plc financial statements, including revenue, expenses, profit, and loss
The total revenue of BDRX for the last semiannual is 104.00 k USD, and it's 71.70% lower compared to the previous semiannual. The net income of H2 23 is -4.40 M USD.